Akdeniz Hall (Hall 2)
The Pharmaceutical Technologies and API Symposium brings together academia, public institutions, and industry to address the full value chain of pharmaceuticals—from R&D to manufacturing—through a multidisciplinary perspective encompassing biotechnology, artificial intelligence, GMP processes, and clinical research, fostering knowledge exchange and collaboration.
Following the opening remarks, the session will address regulatory perspectives on GMP Guide Annex 22 and artificial intelligence applications; subsequently, the journey of biotechnological drugs from R&D to production will be comprehensively explored, with expert insights on biosimilars, clinical exemptions, and domestic manufacturing strategies.
>Prof. Dr. Ali Demir SEZER, Marmara University Faculty of Pharmaceuticals
>Prof. Dr. Ümit KERVAN, TÜSEB President
>Hüseyin ÇELİK, TİTCK President
Innovation in Pharmaceuticals: From Scientific Breakthrough to Regulatory Transformation
> Digital Transformation of eCTD and Regulatory Affairs, Ömer Hakan ŞİMŞEK
> Clinical Trials of Biosimilar Products and Innovative Approaches, S. Ayla ÖZSAR
Digital Transformation in Regulatory Affairs: Shaping the Future of Regulation with People, Data, and AI, from Application to Decision
Moderator: Derya DÖNMEZ, Pharm., Regulatory Affairs Director at Sanofi Turkey
> Yusuf İzzet AKA, Project Management Director at T.C. Health
> Umut AĞYÜZ, Digital Project Manager at the Ministry of Health
> Karen PHILIPPE, Generative AI (GenAI) Regulatory Lead at Sanofi
The Future of National and International Pharmaceutical Markets: Potential Challenges and Solution Scenarios
Moderatör: Op. Dr. Sami TÜRKOĞLU, TISD General Secretary
>Umit DERELI, Secretary General of AIFD
>Savas MALKOC, Secretary General of IEIS
>Sami TURKOGLU, MD, Secretary General of TISD
Bu başlığın İngilizce karşılığı için bağlama göre değerlendirebileceğiniz seçenekler: Kurumsal & Stratejik Yayın Raporu Beyond the Value of Biotechnological Medicines: Strategic Contribution to the Healthcare System
> Dr. Bilgen DÖLEK UÇAROL, Value, Access & Policy and Corporate Affairs Director at Amgen Turkey
Current Applications of Personalized Medicine via Genomic Approaches
> Prof. Dr. Fatma Duygu ÖZEL DEMİRALP, President of Biotechnology Institute of Türkiye
> Dr. Öğr. Üyesi Rizvan İMAMOĞLU, Researcher, Biotechnology Institute of Türkiye
Turkey’s Position and Future in the Global Biopharmaceutical Sector
> Dr. Hasan Ersin ZEYTİN, CEO of Yerlika
Novel Biotechnological Molecules and Production Technologies in National and International Markets
Moderatör: Prof.Dr. Ali Demir SEZER
>Dr. Bilgen DÖLEK UÇAROL, Market Access, Health Policy & Corporate Affairs Director at Amgen Turkey
>Dr. Hasan Ersin ZEYTİN, CEO of YERLIKA
>Ecz. Onur PINARBAŞLI, R&D Director of ILKO
>Levent GÜNDEĞER, EEMEA Regional Director, CYTIVA Türkiye
The Pharmaceutical Technologies and API Symposium brings together academia, public institutions, and industry to address the full value chain of pharmaceuticals—from R&D to manufacturing—through a multidisciplinary perspective encompassing biotechnology, artificial intelligence, GMP processes, and clinical research, fostering knowledge exchange and collaboration.
>Prof. Dr. Ali Demir SEZER, Marmara University Faculty of Pharmaceuticals
>Prof. Dr. Orhan AYDIN, TÜBİTAK President
>Doç. Dr. Eren USUL, General Manager of SGK General Health Insurance
R&D Ecosystem and Supports for Biotechnological Drugs in TÜBİTAK
> Işık AŞAR, Acting Coordinator of BIYOTEG - TÜBİTAK TEYDEB
The Importance of Innovation in Industry-Academia Collaboration
> Prof. Dr. Ersoy KOCABIÇAK, Rector of Istanbul Atlas University
Localization in Pharmaceuticals Indutry: Human Resources, Infrastructure, and Ecosystem Model
Moderatör: M. Adil KAYA, Atabay İlaç ve Kimya Sanayi
> Prof. Dr. Mutlu AYTEMİR, Hacettepe University The Dean of Faculty of Pharmaceuticals
> Berk ÖZDEMİR, CEO of OMEGA Research
> Erdinç YAŞRİN, TİYSAT President
Biopharmaceutical Development Processes
Moderator: Prof. Dr. Ali Osman KILIÇ, İzmir Biomedicine and Genome Center
> Dr. Sibel KALYONCU - Dr. Ayça Z. KUYUCU
From Discovery to Candidate Product: The Biopharmaceutical Development Journey
> Specialist Pharmacist Ayşegül DEMİRTAŞ
Preclinical Pharmacology and Toxicology Studies for Biopharmaceutical Candidates
Regulation and Novel Approaches in Cell and Gene Therapy
> Prof. Dr. Tunç AKKOÇ, Marmara Univ. School of Medicine, Dept. of Basic Medical Sciences
> Prof. Dr. Fatih Süheyl EZGÜ, Gazi Univ. School of Medicine
Clinical Trials and Artificial Intelligence in Biopharmaceuticals
Moderator: Prof. Dr. Yağız ÜRESİN, Istanbul University
> Dr. Chem. Ayla ÖZSAR, Head of Clinical Trials Department at TİTCK
> Umut MÜREN, Clinical Research Unit Director, Sanofi Turkey and Middle East
> Assoc. Prof. Dr. Mustafa ÜNAL, Head of Clinical Research Department, TÜSEB
> Birkan AVER, Medical Area Manager, Primary Care, Pfizer Turkey
> Gülay Gökçe ÖZEL, Director of Clinical Research Turkey, Thermo Fisher Scientific
Open to invited participants only.
Prof. Dr. Ali Demir SEZER, Marmara University Faculty of Pharmaceuticals
Table 1: Clinical Researh-Moderator/ Prof. Dr. Ali Yağız Üresin
Table 2: Regulatory Affairs-Moderator/ Prof. Dr. Ali Demir Sezer
Table 3: Pharmaco Economy-Moderator/ Prof. Dr. Zafer Çalışkan
Table 4: Moderatör/ Haşim Solmaz
Searching for the Future Together in the Pharmaceutical Industry
> Hüseyin ÇELİK, TİTCK President
> Prof. Dr. Ali Demir Sezer
> Prof. Dr. Ali Yağız Üresin
> Prof. Dr. Zafer Çalışkan
> Haşim Solmaz
BIOEXPO 2026 Declaration and Next Year Commitments Announcement
> Session Manager / Hüseyin ÇELİK, TİTCK President
